Grand Island, USA

Fresenius Kabi USA develops, manufactures and markets injectable pharmaceuticals, with important products in the oncology, anti-infective, anaesthetic / analgesic and critical care fields. Fresenius Kabi USA operates out of three sites, located in upstate New York, North Carolina and Illinois.

The Grand Island facility is located just a few minutes from the spectacular Niagara Falls, near Buffalo, NY. The site employs approximately 900 people in three buildings. A two-building site expansion is underway with leading industry isolator filling technology and additional lyophilizers.

Technologies:

  • Lyophilization
  • Aseptic liquid filling
  • Terminal sterilization

Products:

  • Oncologics
  • Anti-infectives
  • Anaesthetics
  • Analgesics
  • Critical care
  • Schedule II & IV Controlled Drugs

Containers:

Certificates:

  • US-FDA
  • Canada-Health Canada
  • DEA

Markets:

  • USA